Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Firefly Neuroscience (AIFF) over the last 12 years, with Q3 2025 value amounting to $464939.0.

  • Firefly Neuroscience's Gains from Investment Securities fell 2033.03% to $464939.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $464939.0, marking a year-over-year decrease of 2033.03%. This contributed to the annual value of $470061.0 for FY2024, which is 24992.22% up from last year.
  • As of Q3 2025, Firefly Neuroscience's Gains from Investment Securities stood at $464939.0, which was down 2033.03% from $470061.0 recorded in Q4 2024.
  • Over the past 5 years, Firefly Neuroscience's Gains from Investment Securities peaked at $912000.0 during Q2 2022, and registered a low of $12609.0 during Q1 2022.
  • In the last 5 years, Firefly Neuroscience's Gains from Investment Securities had a median value of $383719.5 in 2021 and averaged $399872.5.
  • Per our database at Business Quant, Firefly Neuroscience's Gains from Investment Securities crashed by 7884.62% in 2021 and then soared by 44496.95% in 2023.
  • Over the past 5 years, Firefly Neuroscience's Gains from Investment Securities (Quarter) stood at $302500.0 in 2021, then tumbled by 56.63% to $131200.0 in 2022, then increased by 2.39% to $134333.0 in 2023, then skyrocketed by 249.92% to $470061.0 in 2024, then fell by 1.09% to $464939.0 in 2025.
  • Its last three reported values are $464939.0 in Q3 2025, $470061.0 for Q4 2024, and $583583.0 during Q3 2024.